Accelerating Therapeutic DiscoveryTM

The Alpha-1 Project provides access to individuals with Alpha-1 willing to participate in clinical trials through the following Alpha-1 Foundation programs.

Alpha-1 Research Registry Program at the Medical University of South Carolina

The Alpha-1 Research Registry is a confidential database of individuals diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1) and persons identified as Alpha-1 carriers. It serves as a resource for investigators seeking individuals with Alpha-1 to participate in clinical trials, surveys, and other scientific and medical data collection activities.

The Registry’s Family Linkage Program facilitates genetic research and other studies requiring family member participation while protecting the privacy and autonomy of each family member. The Registry is also a vital component to other Alpha-1 research endeavors such as the Alpha-1 Coded Testing (ACT) Study.

The Registry is conducted under the direction of Charlie Strange, M.D. at the Medical University of South Carolina. For more information about the Registry Program, you may visit the website,, email or call toll free, 1-877-886-2383.

Back to Top

The Alpha-1 Foundation DNA and Tissue Bank at the University of Florida

The Alpha-1 Foundation DNA and Tissue Bank at the University of Florida has reached a milestone—the completion of enrollment.

The bank, established in 2002, has more than 2,300 members enrolled and is available for researchers to request medical information (the names of donors are not revealed) and samples for research projects. No further enrollment is anticipated at this time, and no new samples are being accepted.

Almost all enrolled subjects have provided medical information and blood samples. In addition, pulmonary function and liver enzyme testing results are a part of the bank’s data set. The DNA and Tissue Bank is under the direction of Mark Brantly, M.D.

The Alpha-1 Foundation DNA and Tissue Bank is the central storage location for DNA and tissue samples both from people with Alpha-1 Antitrypsin Deficiency and from people who do not have the deficiency, but simply wished to donate their DNA or tissue.

The Bank is a resource for DNA and tissue samples that are studied by researchers investigating Alpha-1 and other diseases.

Researchers needing information on how to obtain samples of DNA and tissue should contact Randel Plant, Director of Research Administration, Alpha-1 Foundation at or at 1-888-825-7421 ext 242.

About The Alpha-1 Project

The Alpha-1 Project (TAP) is a wholly owned subsidiary of the Alpha-1 Foundation singularly focused on bridging the gap between clinical trials and commercialization of therapies for the elimination of Chronic Obstructive Pulmonary Disease (COPD) and liver disease caused by Alpha-1 Antitrypsin Deficiency (Alpha-1).

Learn More

Latest News

Posted on November 18, 2019
Arrowhead Pharmaceuticals Inc., has dosed the first patient in SEQUOIA (AROAAT2001), a potentially pivotal Phase 2/3 clinical...
Posted on August 08, 2019

General Contact

The Alpha-1 Project

3300 Ponce de Leon Boulevard
Coral Gables, FL 33134
Phone: 305-648-9541
Toll-free: 888-920-0002
Fax: 305-441-2110